Services

Histology

Pharmacology

Medical Device Testing

In Vitro Screening

Animal Model Development

Custom Assay Development

Vivarium Rental

Toxicology

Species

Non-human Primates

Dogs

Mini-pigs / Pigs

Rabbits

Mice

Rats

Sheep

Guinea Pigs

Hamsters

Other Species

Therapeutic Areas

Oncology

Immunology & Inflammation

Neurology / CNS

Cardiovascular

Dermatology & Wound Healing

Metabolism

Gastroenterology

Hepatology

Pulmonology

Infectious Diseases & Sepsis

Musculoskeletal

Nephrology & Urology

Capabilities

GLP / IND-Enabling Studies

Small and Large Animal Housing

Bioanalytical Platforms

About

News

Contact

Career

Request a Quote

☰

Patient Death Forces Alnylam to Suspend Dosing in Hemophilia Trial, Stock Plunges

  • Post author:
  • Post category:BioPharma

<IMG SRC"http://enewsletters.biospace.com/images/news/biospace-news-815x450-stocks2.jpg" NAME"Patient Death Forces Alnylam to Suspend Dosing in Hemophilia Trial, Stock Plunges" ALT"Patient Death Forces Alnylam to Suspend Dosing in Hemophilia Trial, Stock Plunges"September 7, 2017By Mark Terry,…

Continue ReadingPatient Death Forces Alnylam to Suspend Dosing in Hemophilia Trial, Stock Plunges

FDA Orders 6 Partial or Full Clinical Holds on Celgene's Blood Cancer Studies

  • Post author:
  • Post category:BioPharma

<IMG SRC"http://enewsletters.biospace.com/images/news/biospace-news-815x450-celgene.jpg" NAME"FDA Orders 6 Partial or Full Clinical Holds on Celgene's Blood Cancer Studies" ALT"FDA Orders 6 Partial or Full Clinical Holds on Celgene's Blood Cancer Studies"September 7, 2017By…

Continue ReadingFDA Orders 6 Partial or Full Clinical Holds on Celgene's Blood Cancer Studies

FDA Slaps Partial Hold on 3 of Bristol-Myers Squibb's Opdivo-Based Combo Trials

  • Post author:
  • Post category:BioPharma

<IMG SRC"http://enewsletters.biospace.com/images/news/biospace-news-815x450-bristol-myers-squibb.jpg" NAME"FDA Slaps Partial Hold on 3 of Bristol-Myers Squibb's Opdivo-Based Combo Trials" ALT"FDA Slaps Partial Hold on 3 of Bristol-Myers Squibb's Opdivo-Based Combo Trials"September 7, 2017By Mark Terry...…

Continue ReadingFDA Slaps Partial Hold on 3 of Bristol-Myers Squibb's Opdivo-Based Combo Trials

<b>GBSI</b> Biopolicy Summit 2017 Explores Newest Lab Automation, Digital Tools And Technologies Promising Improved Preclinical Research Reproducibility — October 16 In San Francisco

  • Post author:
  • Post category:BioPharma

  Life Sciences Jobs   ... Source: BioSpace

Continue Reading<b>GBSI</b> Biopolicy Summit 2017 Explores Newest Lab Automation, Digital Tools And Technologies Promising Improved Preclinical Research Reproducibility — October 16 In San Francisco

After a Billion+ Loss to Alzheimer's at Medivation, Takes Another Shot at Axovant

  • Post author:
  • Post category:BioPharma

<IMG SRC"http://enewsletters.biospace.com/images/news/biospace-news-815x430-axovant-david-hung.jpg" NAME"After a Billion Loss to Alzheimer's at Medivation, Hung Takes Another Shot at Ramaswamy's Axovant" ALT"After a Billion Loss to Alzheimer's at Medivation, Hung Takes Another Shot at…

Continue ReadingAfter a Billion+ Loss to Alzheimer's at Medivation, Takes Another Shot at Axovant

Verastem Soars as Blood Cancer Drug Succeeds in Phase III Study

  • Post author:
  • Post category:BioPharma

<IMG SRC"http://enewsletters.biospace.com/images/news/biospace-news-815x450-stocks.jpg" NAME"Verastem Soars as Blood Cancer Drug Succeeds in Phase III Study" ALT"Verastem Soars as Blood Cancer Drug Succeeds in Phase III Study"September 6, 2017By Alex Keown, BioSpace.com Breaking…

Continue ReadingVerastem Soars as Blood Cancer Drug Succeeds in Phase III Study